Geselecteerde datamodellen

U moet ingelogd zijn om meerdere datamodellen te selecteren en die te downloaden of te analyseren.

66 Zoekresultaten.
Relevantie Beoordeling Nieuwe eerst Oude eerst

Laboratory Visit 06 SirTac NCT02936388 - Laboratory Visit 06

- 31-01-22 - 1 Formulier, 1 Itemgroep, 29 Data-elementen, 1 Taal
Itemgroep: Laboratory
Study part: Laboratory Visit 06. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory Visit 08 SirTac NCT02936388 - Laboratory Visit 08

- 31-01-22 - 1 Formulier, 1 Itemgroep, 29 Data-elementen, 1 Taal
Itemgroep: Laboratory
Study part: Laboratory Visit 08. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory Visit 05 SirTac NCT02936388 - Laboratory Visit 05

- 31-01-22 - 1 Formulier, 1 Itemgroep, 29 Data-elementen, 1 Taal
Itemgroep: Laboratory
Study part: Laboratory Visit 05. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory Visit 01 SirTac NCT02936388 - Laboratory Visit 01

- 31-01-22 - 1 Formulier, 1 Itemgroep, 29 Data-elementen, 1 Taal
Itemgroep: Laboratory
Study part: Laboratory Visit 01. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory 6- Weeks Visits SirTac NCT02936388 - Laboratory 6- Weeks Visits

- 31-01-22 - 1 Formulier, 1 Itemgroep, 29 Data-elementen, 1 Taal
Itemgroep: Laboratory
Study part: Laboratory 6- Weeks Visits. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory Visit 07 SirTac NCT02936388 - Laboratory Visit 07

- 31-01-22 - 1 Formulier, 1 Itemgroep, 29 Data-elementen, 1 Taal
Itemgroep: Laboratory
Study part: Laboratory Visit 07. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory Visit 03 SirTac NCT02936388 - Laboratory Visit 03

- 31-01-22 - 1 Formulier, 1 Itemgroep, 29 Data-elementen, 1 Taal
Itemgroep: Laboratory
Study part: Laboratory Visit 03. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory Visit 04 SirTac NCT02936388 - Laboratory Visit 04

- 31-01-22 - 1 Formulier, 1 Itemgroep, 29 Data-elementen, 1 Taal
Itemgroep: Laboratory
Study part: Laboratory Visit 04. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory Before every SIRT- or TACE- Treatment SirTac NCT02936388 - Laboratory Before every SIRT- or TACE- Treatment

- 31-01-22 - 1 Formulier, 1 Itemgroep, 29 Data-elementen, 1 Taal
Itemgroep: Laboratory
Study part: Laboratory Before every SIRT- or TACE- Treatment. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory Screening Day -7 to 0 SirTac NCT02936388 - Laboratory Screening Day -7 to 0

- 31-01-22 - 1 Formulier, 1 Itemgroep, 28 Data-elementen, 1 Taal
Itemgroep: Laboratory
Study part: Laboratory Screening Day -7 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory Screening Day -7 to 0 SirTac NCT02936388 - Laboratory Screening Day -7 to 0

- 31-01-22 - 1 Formulier, 1 Itemgroep, 28 Data-elementen, 1 Taal
Itemgroep: Laboratory
Study part: Laboratory Screening Day -7 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory End of Therapy SirTac NCT02936388 - Laboratory End of Therapy

- 31-01-22 - 1 Formulier, 1 Itemgroep, 29 Data-elementen, 1 Taal
Itemgroep: Laboratory
Study part: Laboratory End of Therapy. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial